Breast & ovarian cancer. Issues in risk assessment.
Caro
S W
SW
Vanderbilt Breast Center, Vanderbilt University Medical Center, Nashville, USA.
D024682:BRCA2 Protein; D001943:Breast Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics* / Q000517:prevention & control*; D005260:Female; D019398:Genes, BRCA1 / Q000235:genetics; D005820:Genetic Testing / Q000379:methods*; D006801:Humans; D008875:Middle Aged; D009154:Mutation / Q000235:genetics; D009363:Neoplasm Proteins / Q000235:genetics; D009722:Nurse Practitioners; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics* / Q000517:prevention & control*; D010375:Pedigree; D012017:Referral and Consultation; D018570:Risk Assessment; D012307:Risk Factors; D014157:Transcription Factors / Q000235:genetics
D024682:BRCA2 Protein; D009363:Neoplasm Proteins; D014157:Transcription Factors